Phosphatidylserine Containing Liposomes Reduce Immunogenicity of Recombinant Human Factor VIII (rFVIII) in a Murine Model of Hemophilia A**Karthik Ramani and Razvan D. Miclea contributed equally to the manuscript.
- 1 April 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 97 (4), 1386-1398
- https://doi.org/10.1002/jps.21102
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Lipid Binding Region (2303–2332) is Involved in Aggregation of Recombinant Human FVIII (rFVIII)**Karthik Ramani and Vivek S. Purohit have contributed equally to this work.Journal of Pharmaceutical Sciences, 2005
- Pharmacokinetic aspects of biotechnology productsJournal of Pharmaceutical Sciences, 2004
- Inhibitors in hemophilia ABlood Coagulation & Fibrinolysis, 2004
- Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding siteThrombosis and Haemostasis, 2004
- Immunobiology of Inhibitor Development in Hemophilia ASeminars in Thrombosis and Hemostasis, 2003
- Hemophilia A-From Basic Science to Clinical PracticeSeminars in Thrombosis and Hemostasis, 2002
- Bioequivalence and the immunogenicity of biopharmaceuticalsNature Reviews Drug Discovery, 2002
- Conformational Origin of the Aggregation of Recombinant Human Factor VIIIBiochemistry, 2000
- Targeted disruption of the mouse factor VIII gene produces a model of haemophilia ANature Genetics, 1995
- Participation of cathepsin B in processing of antigen presentation to MHC class IIFEBS Letters, 1993